| __timestamp | Amneal Pharmaceuticals, Inc. | Bausch Health Companies Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 335989000 | 2254600000 |
| Thursday, January 1, 2015 | 367054000 | 2645000000 |
| Friday, January 1, 2016 | 420770000 | 2611000000 |
| Sunday, January 1, 2017 | 507476000 | 2548000000 |
| Monday, January 1, 2018 | 946588000 | 2351000000 |
| Tuesday, January 1, 2019 | 1273376000 | 2350000000 |
| Wednesday, January 1, 2020 | 1364130000 | 2249000000 |
| Friday, January 1, 2021 | 1324696000 | 2394000000 |
| Saturday, January 1, 2022 | 1427596000 | 2364000000 |
| Sunday, January 1, 2023 | 1573042000 | 2559000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. This analysis delves into the cost of revenue trends for Amneal Pharmaceuticals, Inc. and Bausch Health Companies Inc. from 2014 to 2023. Over this period, Amneal Pharmaceuticals saw a staggering 368% increase in its cost of revenue, peaking at approximately $1.57 billion in 2023. In contrast, Bausch Health Companies maintained a relatively stable cost structure, with a modest 13% increase, reaching around $2.56 billion in the same year.
The data reveals a significant divergence in cost management strategies between these two companies. While Amneal's costs surged, possibly due to expansion or increased production, Bausch's steady figures suggest a focus on efficiency and cost control. This comparison offers valuable insights into how different strategies can impact financial outcomes in the competitive pharmaceutical landscape.
Cost of Revenue Comparison: Eli Lilly and Company vs Amneal Pharmaceuticals, Inc.
Cost of Revenue Comparison: Novartis AG vs Amneal Pharmaceuticals, Inc.
Gilead Sciences, Inc. vs Amneal Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Zoetis Inc. vs Amneal Pharmaceuticals, Inc.
Bio-Techne Corporation vs Amneal Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
BioMarin Pharmaceutical Inc. vs Bausch Health Companies Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Walgreens Boots Alliance, Inc. vs Amneal Pharmaceuticals, Inc.
Cost of Revenue Trends: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Comparing Cost of Revenue Efficiency: Amneal Pharmaceuticals, Inc. vs Veracyte, Inc.
Cost of Revenue Comparison: Amneal Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.
Cost Insights: Breaking Down Bausch Health Companies Inc. and Vericel Corporation's Expenses
Comparing Cost of Revenue Efficiency: Bausch Health Companies Inc. vs Mesoblast Limited